CA2979873C - Methode de traitement d'une infection bacterienne - Google Patents

Methode de traitement d'une infection bacterienne

Info

Publication number
CA2979873C
CA2979873C CA2979873A CA2979873A CA2979873C CA 2979873 C CA2979873 C CA 2979873C CA 2979873 A CA2979873 A CA 2979873A CA 2979873 A CA2979873 A CA 2979873A CA 2979873 C CA2979873 C CA 2979873C
Authority
CA
Canada
Prior art keywords
agent
host cell
intracellular
bactericidal
effective amount
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CA2979873A
Other languages
English (en)
Other versions
CA2979873A1 (fr
Inventor
Fritz Eichenseher
Original Assignee
Micreos Human Health BV
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Micreos Human Health BV filed Critical Micreos Human Health BV
Priority claimed from PCT/EP2016/055076 external-priority patent/WO2016142445A2/fr
Publication of CA2979873A1 publication Critical patent/CA2979873A1/fr
Application granted granted Critical
Publication of CA2979873C publication Critical patent/CA2979873C/fr
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Abstract

La présente invention concerne le domaine de la médecine, plus spécifiquement le domaine d'une infection bactérienne et le traitement de celle-ci.
CA2979873A 2015-03-12 2016-03-10 Methode de traitement d'une infection bacterienne Active CA2979873C (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP15158880 2015-03-12
EP15158880.3 2015-03-12
PCT/EP2016/055076 WO2016142445A2 (fr) 2015-03-12 2016-03-10 Méthode de traitement d'une infection bactérienne

Publications (2)

Publication Number Publication Date
CA2979873A1 CA2979873A1 (fr) 2016-09-15
CA2979873C true CA2979873C (fr) 2026-03-24

Family

ID=

Similar Documents

Publication Publication Date Title
US11690899B2 (en) Combination of bactericidal agent with a lysosomotropic alkalinising agent for the treatment of a bacterial infection
Kim et al. Antimicrobial activity of LysSS, a novel phage endolysin, against Acinetobacter baumannii and Pseudomonas aeruginosa
Boparai et al. Mini review on antimicrobial peptides, sources, mechanism and recent applications
Wang et al. A phage lysin fused to a cell-penetrating peptide kills intracellular methicillin-resistant Staphylococcus aureus in keratinocytes and has potential as a treatment for skin infections in mice
DK2938352T3 (en) CYLIC CATIONIC PEPTIDES WITH ANTIBMICROBIAL ACTIVITY
JP2015522533A (ja) 抗菌活性を有するポリペプチドミックス
US11857606B2 (en) Therapeutic bacteriocins
KR20180002618A (ko) 항균 펩티드 및 이의 사용방법
CN112166190A (zh) 新抗微生物蛋白
Pepperney et al. Antibacterial peptides: opportunities for the prevention and treatment of dental caries
KR20210014674A (ko) 신규 항균성 융합 단백질
CN109072211A (zh) 抗沙门氏菌的抗菌剂
CN115397994A (zh) 新型多肽、融合多肽和包含其的抗革兰氏阴性菌的抗生素
US20250288652A1 (en) Bacteriophage lysine, chimera thereof and application thereof
AU2017263563A1 (en) Broth microdilution method for evaluating and determining minimal inhibitory concentration of antibacterial polypeptides
E Shepherd et al. Targeting quorum sensing and competence stimulation for antimicrobial chemotherapy
KR20230028132A (ko) 신규한 폴리펩타이드 및 이를 포함하는 그람음성균에 대한 항생제
CA2979873C (fr) Methode de traitement d'une infection bacterienne
CA2556351A1 (fr) Agents antimicrobiens
HK1249033B (en) Combination of bactericidal agent with a lysosomotropic alkalinising agent for the treatment of a bacterial infection
Dullius et al. Are peptides a solution for the treatment of hyperactivated JAK3 pathways? A. Dullius et al.
BR112017019413B1 (pt) Uso de um agente que aumenta o ph intracelular de uma célula hospedeira e/ou de um compartimento intracelular de uma célula hospedeira e de um agente bactericida para o tratamento de uma infecção bacteriana
Vogel How Streptococcus anginosus kills competitors–Identification and characterization of the novel bacteriocin Angicin
Jindal Hybrid Peptides Derived from Natural Antimicrobial Peptides, Indolicidin and Ranalexin, Exhibit Potent Antimicrobial Activities Against Streptococcus Pneumoniae in Vitro and in Vivo
Hassan Mahmood Hybrid peptides derived from natural antimicrobial peptides, indolicidin and ranalexin, exhibit potent antimicrobial activities against Streptococcus pneumoniae in vitro and in vivo/Hassan Mahmood Kzar Jindal